Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A
Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was needed for further...
Main Authors: | Anna K. Krome, Tim Becker, Stefan Kehraus, Andrea Schiefer, Christian Steinebach, Tilman Aden, Stefan J. Frohberger, Álvaro López Mármol, Dnyaneshwar Kapote, Rolf Jansen, Lillibeth Chaverra-Muñoz, Marc P. Hübner, Kenneth Pfarr, Thomas Hesterkamp, Marc Stadler, Michael Gütschow, Gabriele M. König, Achim Hoerauf, Karl G. Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/11/1105 |
Similar Items
-
In Vitro–In Vivo Relationship in Mini-Scale—Enabling Formulations of Corallopyronin A
by: Tim Becker, et al.
Published: (2022-08-01) -
The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in <i>Staphylococcus aureus</i>
by: Jan Balansky, et al.
Published: (2022-07-01) -
Elaborations on Corallopyronin A as a Novel Treatment Strategy Against Genital Chlamydial Infections
by: Nathalie Loeper, et al.
Published: (2019-05-01) -
Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A
by: Jennifer L. Edwards, et al.
Published: (2022-10-01) -
Povidone-iodine in wound healing and prevention of wound infections
by: Maksym K. Gmur, et al.
Published: (2020-06-01)